Skip to main content
. 2021 Nov 8;94(3):1085–1095. doi: 10.1002/jmv.27424

Figure 2.

Figure 2

Comparative safety of mRNA COVID‐19 vaccines versus influenza vaccines with respect to serious adverse events after immunization (AEFIs). Adj‐ROR, adjusted reported odd ratios; 95% CI, 95% confidential interval; mRNA, messenger RNA